Argentarii’s MiMedx Group MDXG Stock Holding History

Argentarii’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,666	Closed	-$160K	–	169
2024 Q4	$160K	Buy	+16,666	New	+$130K	0.08%	157

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Argentarii's MDXG Position: Q1 2025 in Review

Argentarii sold out of MiMedx Group (MDXG) in Q1 2025, closing a stake of 16,666 shares — an estimated $160K sold.

Argentarii first reported a position in MDXG in Q4 2024 and held it in 1 quarter. The position peaked at $160K in Q4 2024. 218 funds tracked by Wall St. Rank hold MDXG as of Q1 2025.

Argentarii reported no remaining MiMedx Group position as of Q1 2025 after selling out during the quarter.
Argentarii sold 16,666 MiMedx Group shares in Q1 2025, an estimated $160K.
Argentarii first reported a position in MiMedx Group in Q4 2024 and held it in 1 quarter.
Argentarii's MiMedx Group position peaked at $160K in Q4 2024.
218 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2025.

Based on Argentarii's 13F filing for Q1 2025, filed 29 Apr 2025.